Global Cancer Diagnostics Professional Market Insights, Players, Region, Type & Application Analysis 2018-2029
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Cancer Diagnostics market size in 2022 is 16700.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 7.70% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Cancer Diagnostics market include Abbott. (U.S.), DiagnoCure Inc. (Canada), Thermo Fisher Scientific (U.S.), Illumina, Inc. (U.S.), and QIAGEN (Germany). The share of the top 3 players in the Cancer Diagnostics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Cancer Diagnostics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Software accounted for XX% of Cancer Diagnostics market in 2022. Services share of XX%.
Lung Cancer accounted for XX% of the Cancer Diagnostics market in 2022. Breast Cancer accounts for XX%.
The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Cancer Diagnostics markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.
Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.
Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers' contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.
The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Market Data Breakdown by Regions
North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa
Some prominent players in the market includes:
Abbott. (U.S.)
DiagnoCure Inc. (Canada)
Thermo Fisher Scientific (U.S.)
Illumina, Inc. (U.S.)
QIAGEN (Germany)
F. Hoffmann-La Roche Ltd (Switzerland)
Agilent Technologies, Inc. (U.S.)
Quest Diagnostics Incorporated. (U.S.)
Merck KGaA, (Germany)
Hologic, Inc. (U.S.)
BD. (U.S.)
GSK plc. (U.K.)
Novartis AG (Switzerland)
Bristol-Myers Squibb Company (U.S.)
Lilly (U.S.)
Pfizer, Inc. (U.S.)
Genomic Health, Inc. (U.S.)
bioMérieux SA (France)
Astellas Pharma Inc. (Japan)
Myriad Genetics, Inc. (U.S.)
Market Data Breakdown by Type
Software
Services
Market Data Breakdown by Applications
Lung Cancer
Breast Cancer
Colorectal Cancer
Melanoma Cancer
Prostate Cancer
Liver Cancer
Others
Table of Content
1 Cancer Diagnostics Market Introduction and Overview
1.1 Cancer Diagnostics Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Cancer Diagnostics Revenue and Market Share by Manufacturer
2.2 Manufacturers Cancer Diagnostics Production Sites, Area Served, Product Types
2.3 Cancer Diagnostics Market Competitive Situation and Trends
2.3.1 Cancer Diagnostics Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Abbott. (U.S.)
3.1.1 Abbott. (U.S.) Company Profile
3.1.2 Cancer Diagnostics Product Overview
3.1.3 Abbott. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.1.4 Abbott. (U.S.) Business Overview
3.2 DiagnoCure Inc. (Canada)
3.2.1 DiagnoCure Inc. (Canada) Company Profile
3.2.2 Cancer Diagnostics Product Overview
3.2.3 DiagnoCure Inc. (Canada) Cancer Diagnostics Market Performance (2018-2023)
3.2.4 DiagnoCure Inc. (Canada) Business Overview
3.3 Thermo Fisher Scientific (U.S.)
3.3.1 Thermo Fisher Scientific (U.S.) Company Profile
3.3.2 Cancer Diagnostics Product Overview
3.3.3 Thermo Fisher Scientific (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.3.4 Thermo Fisher Scientific (U.S.) Business Overview
3.4 Illumina, Inc. (U.S.)
3.4.1 Illumina, Inc. (U.S.) Company Profile
3.4.2 Cancer Diagnostics Product Overview
3.4.3 Illumina, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.4.4 Illumina, Inc. (U.S.) Business Overview
3.5 QIAGEN (Germany)
3.5.1 QIAGEN (Germany) Company Profile
3.5.2 Cancer Diagnostics Product Overview
3.5.3 QIAGEN (Germany) Cancer Diagnostics Market Performance (2018-2023)
3.5.4 QIAGEN (Germany) Business Overview
3.6 F. Hoffmann-La Roche Ltd (Switzerland)
3.6.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profile
3.6.2 Cancer Diagnostics Product Overview
3.6.3 F. Hoffmann-La Roche Ltd (Switzerland) Cancer Diagnostics Market Performance (2018-2023)
3.6.4 F. Hoffmann-La Roche Ltd (Switzerland) Business Overview
3.7 Agilent Technologies, Inc. (U.S.)
3.7.1 Agilent Technologies, Inc. (U.S.) Company Profile
3.7.2 Cancer Diagnostics Product Overview
3.7.3 Agilent Technologies, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.7.4 Agilent Technologies, Inc. (U.S.) Business Overview
3.8 Quest Diagnostics Incorporated. (U.S.)
3.8.1 Quest Diagnostics Incorporated. (U.S.) Company Profile
3.8.2 Cancer Diagnostics Product Overview
3.8.3 Quest Diagnostics Incorporated. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.8.4 Quest Diagnostics Incorporated. (U.S.) Business Overview
3.9 Merck KGaA, (Germany)
3.9.1 Merck KGaA, (Germany) Company Profile
3.9.2 Cancer Diagnostics Product Overview
3.9.3 Merck KGaA, (Germany) Cancer Diagnostics Market Performance (2018-2023)
3.9.4 Merck KGaA, (Germany) Business Overview
3.10 Hologic, Inc. (U.S.)
3.10.1 Hologic, Inc. (U.S.) Company Profile
3.10.2 Cancer Diagnostics Product Overview
3.10.3 Hologic, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.10.4 Hologic, Inc. (U.S.) Business Overview
3.11 BD. (U.S.)
3.11.1 BD. (U.S.) Company Profile
3.11.2 Cancer Diagnostics Product Overview
3.11.3 BD. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.11.4 BD. (U.S.) Business Overview
3.12 GSK plc. (U.K.)
3.12.1 GSK plc. (U.K.) Company Profile
3.12.2 Cancer Diagnostics Product Overview
3.12.3 GSK plc. (U.K.) Cancer Diagnostics Market Performance (2018-2023)
3.12.4 GSK plc. (U.K.) Business Overview
3.13 Novartis AG (Switzerland)
3.13.1 Novartis AG (Switzerland) Company Profile
3.13.2 Cancer Diagnostics Product Overview
3.13.3 Novartis AG (Switzerland) Cancer Diagnostics Market Performance (2018-2023)
3.13.4 Novartis AG (Switzerland) Business Overview
3.14 Bristol-Myers Squibb Company (U.S.)
3.14.1 Bristol-Myers Squibb Company (U.S.) Company Profile
3.14.2 Cancer Diagnostics Product Overview
3.14.3 Bristol-Myers Squibb Company (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.14.4 Bristol-Myers Squibb Company (U.S.) Business Overview
3.15 Lilly (U.S.)
3.15.1 Lilly (U.S.) Company Profile
3.15.2 Cancer Diagnostics Product Overview
3.15.3 Lilly (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.15.4 Lilly (U.S.) Business Overview
3.16 Pfizer, Inc. (U.S.)
3.16.1 Pfizer, Inc. (U.S.) Company Profile
3.16.2 Cancer Diagnostics Product Overview
3.16.3 Pfizer, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.16.4 Pfizer, Inc. (U.S.) Business Overview
3.17 Genomic Health, Inc. (U.S.)
3.17.1 Genomic Health, Inc. (U.S.) Company Profile
3.17.2 Cancer Diagnostics Product Overview
3.17.3 Genomic Health, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.17.4 Genomic Health, Inc. (U.S.) Business Overview
3.18 bioMérieux SA (France)
3.18.1 bioMérieux SA (France) Company Profile
3.18.2 Cancer Diagnostics Product Overview
3.18.3 bioMérieux SA (France) Cancer Diagnostics Market Performance (2018-2023)
3.18.4 bioMérieux SA (France) Business Overview
3.19 Astellas Pharma Inc. (Japan)
3.19.1 Astellas Pharma Inc. (Japan) Company Profile
3.19.2 Cancer Diagnostics Product Overview
3.19.3 Astellas Pharma Inc. (Japan) Cancer Diagnostics Market Performance (2018-2023)
3.19.4 Astellas Pharma Inc. (Japan) Business Overview
3.20 Myriad Genetics, Inc. (U.S.)
3.20.1 Myriad Genetics, Inc. (U.S.) Company Profile
3.20.2 Cancer Diagnostics Product Overview
3.20.3 Myriad Genetics, Inc. (U.S.) Cancer Diagnostics Market Performance (2018-2023)
3.20.4 Myriad Genetics, Inc. (U.S.) Business Overview
4 Global Cancer Diagnostics Historical and Forecast Market Analysis by Type
4.1 Global Cancer Diagnostics Revenue and Market Share by Type
4.2 Global Cancer Diagnostics Revenue Market Forecast by Type (2023-2029)
5 Global Cancer Diagnostics Historical and Forecast Market Analysis by Application
5.1 Global Cancer Diagnostics Revenue Market Share by Application (2018-2023)
5.2 Cancer Diagnostics Revenue Market Forecast by Application (2023-2029)
6 Global Market Growth Trends Analysis
6.1 Global Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2 Cancer Diagnostics Growth Trends Analysis by Regions
6.2.1 Cancer Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
6.2.2 Cancer Diagnostics Historic Revenue Market Size by Regions (2018-2023)
6.2.3 Cancer Diagnostics Forecasted Revenue Market Size by Regions (2023-2029)
6.2.4 North America Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.5 Europe Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.6 China Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.7 Japan Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.8 Korea Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.9 Southeast Asia Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.10 India Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.11 South America Cancer Diagnostics Market Size & Forecast (2018-2029)
6.2.12 Middle East & Africa Cancer Diagnostics Market Size & Forecast (2018-2029)
7 North America
7.1 North America Cancer Diagnostics Revenue by Players
7.2 North America Cancer Diagnostics Revenue by Types
7.3 North America Cancer Diagnostics Revenue by Applications
7.4 North America Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Cancer Diagnostics Revenue by Players
8.2 Europe Cancer Diagnostics Revenue by Types
8.3 Europe Cancer Diagnostics Revenue by Applications
8.4 Europe Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
8.5 Europe PEST Analysis
9 China
9.1 China Cancer Diagnostics Revenue by Players
9.2 China Cancer Diagnostics Revenue by Types
9.3 China Cancer Diagnostics Revenue by Applications
9.4 China Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
9.5 China PEST Analysis
10 Japan
10.1 Japan Cancer Diagnostics Revenue by Players
10.2 Japan Cancer Diagnostics Revenue by Types
10.3 Japan Cancer Diagnostics Revenue by Applications
10.4 Japan Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Cancer Diagnostics Revenue by Players
11.2 Korea Cancer Diagnostics Revenue by Types
11.3 Korea Cancer Diagnostics Revenue by Applications
11.4 Korea Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Cancer Diagnostics Revenue by Players
12.2 Southeast Asia Cancer Diagnostics Revenue by Types
12.3 Southeast Asia Cancer Diagnostics Revenue by Applications
12.4 Southeast Asia Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Cancer Diagnostics Revenue by Players
13.2 India Cancer Diagnostics Revenue by Types
13.3 India Cancer Diagnostics Revenue by Applications
13.4 India Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
13.5 India PEST Analysis
14 South America
14.1 South America Cancer Diagnostics Revenue by Players
14.2 South America Cancer Diagnostics Revenue by Types
14.3 South America Cancer Diagnostics Revenue by Applications
14.4 South America Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Cancer Diagnostics Revenue by Players
15.2 Middle East & Africa Cancer Diagnostics Revenue by Types
15.3 Middle East & Africa Cancer Diagnostics Revenue by Applications
15.4 Middle East & Africa Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
15.5 Middle East & Africa PEST Analysis
16 Cancer Diagnostics Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Cancer Diagnostics Industrial Chain Analysis
17 Cancer Diagnostics Industry Dynamic Analysis
17.1 Cancer Diagnostics Market Trends Analysis
17.2 Cancer Diagnostics Market Drivers Analysis
17.3 Cancer Diagnostics Market Challenges Analysis
17.4 Cancer Diagnostics Market Restraints Analysis
18 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Cancer Diagnostics Picture
Table Product Definition of Cancer Diagnostics
Table Global Cancer Diagnostics Market Size by Type (2023 VS 2029)
Figure Global Cancer Diagnostics Market Share by Type 2023 VS 2029
Table Global Cancer Diagnostics Market Size by Application (2023 VS 2029)
Figure Global Cancer Diagnostics Market Share by Application 2023 VS 2029
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Cancer Diagnostics Revenue ($) by Manufacturer (2018-2023)
Table Global Cancer Diagnostics Revenue Market Share by Manufacturer (2018-2023)
Figure Global Cancer Diagnostics Revenue Market Share by Manufacturer in 2023
Table Manufacturers Cancer Diagnostics Production Sites, Area Served, Product Types
Table Cancer Diagnostics Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Abbott. (U.S.) Profile
Table Product Overview
Table Abbott. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Abbott. (U.S.) Revenue and Growth Rate
Figure Abbott. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table DiagnoCure Inc. (Canada) Profile
Table Product Overview
Table DiagnoCure Inc. (Canada) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure DiagnoCure Inc. (Canada) Revenue and Growth Rate
Figure DiagnoCure Inc. (Canada) Revenue Market Share 2017-2022
Table Business Overview
Table Thermo Fisher Scientific (U.S.) Profile
Table Product Overview
Table Thermo Fisher Scientific (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Thermo Fisher Scientific (U.S.) Revenue and Growth Rate
Figure Thermo Fisher Scientific (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Illumina, Inc. (U.S.) Profile
Table Product Overview
Table Illumina, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Illumina, Inc. (U.S.) Revenue and Growth Rate
Figure Illumina, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table QIAGEN (Germany) Profile
Table Product Overview
Table QIAGEN (Germany) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure QIAGEN (Germany) Revenue and Growth Rate
Figure QIAGEN (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table F. Hoffmann-La Roche Ltd (Switzerland) Profile
Table Product Overview
Table F. Hoffmann-La Roche Ltd (Switzerland) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue and Growth Rate
Figure F. Hoffmann-La Roche Ltd (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Agilent Technologies, Inc. (U.S.) Profile
Table Product Overview
Table Agilent Technologies, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Agilent Technologies, Inc. (U.S.) Revenue and Growth Rate
Figure Agilent Technologies, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Quest Diagnostics Incorporated. (U.S.) Profile
Table Product Overview
Table Quest Diagnostics Incorporated. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Quest Diagnostics Incorporated. (U.S.) Revenue and Growth Rate
Figure Quest Diagnostics Incorporated. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Merck KGaA, (Germany) Profile
Table Product Overview
Table Merck KGaA, (Germany) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Merck KGaA, (Germany) Revenue and Growth Rate
Figure Merck KGaA, (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Hologic, Inc. (U.S.) Profile
Table Product Overview
Table Hologic, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Hologic, Inc. (U.S.) Revenue and Growth Rate
Figure Hologic, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table BD. (U.S.) Profile
Table Product Overview
Table BD. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure BD. (U.S.) Revenue and Growth Rate
Figure BD. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table GSK plc. (U.K.) Profile
Table Product Overview
Table GSK plc. (U.K.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure GSK plc. (U.K.) Revenue and Growth Rate
Figure GSK plc. (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table Novartis AG (Switzerland) Profile
Table Product Overview
Table Novartis AG (Switzerland) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Revenue and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table Bristol-Myers Squibb Company (U.S.) Profile
Table Product Overview
Table Bristol-Myers Squibb Company (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Bristol-Myers Squibb Company (U.S.) Revenue and Growth Rate
Figure Bristol-Myers Squibb Company (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Lilly (U.S.) Profile
Table Product Overview
Table Lilly (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Lilly (U.S.) Revenue and Growth Rate
Figure Lilly (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Pfizer, Inc. (U.S.) Profile
Table Product Overview
Table Pfizer, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer, Inc. (U.S.) Revenue and Growth Rate
Figure Pfizer, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Genomic Health, Inc. (U.S.) Profile
Table Product Overview
Table Genomic Health, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Genomic Health, Inc. (U.S.) Revenue and Growth Rate
Figure Genomic Health, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table bioMérieux SA (France) Profile
Table Product Overview
Table bioMérieux SA (France) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure bioMérieux SA (France) Revenue and Growth Rate
Figure bioMérieux SA (France) Revenue Market Share 2017-2022
Table Business Overview
Table Astellas Pharma Inc. (Japan) Profile
Table Product Overview
Table Astellas Pharma Inc. (Japan) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Astellas Pharma Inc. (Japan) Revenue and Growth Rate
Figure Astellas Pharma Inc. (Japan) Revenue Market Share 2017-2022
Table Business Overview
Table Myriad Genetics, Inc. (U.S.) Profile
Table Product Overview
Table Myriad Genetics, Inc. (U.S.) Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. (U.S.) Revenue and Growth Rate
Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Global Cancer Diagnostics Revenue and Market Size by Type (2018-2023)
Table Global Cancer Diagnostics Revenue and Market Share by Type (2018-2023)
Table Global Cancer Diagnostics Revenue Market Size Forecast by Type (2023-2029)
Table Global Cancer Diagnostics Revenue Market Share Forecast by Type (2023-2029)
Table Global Cancer Diagnostics Revenue Market Size by Application (2018-2023)
Table Global Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table Global Cancer Diagnostics Revenue Market Size by Application (2023-2029)
Table Global Cancer Diagnostics Revenue Market Share by Application (2023-2029)
Figure Global Cancer Diagnostics Revenue Market Size & Forecast (2018-2029)
Table Cancer Diagnostics Market Size by Regions: 2018 VS 2023 VS 2029
Table Cancer Diagnostics Historic Revenue Market Size by Regions (2018-2023)
Table Cancer Diagnostics Historic Revenue Market Share by Regions (2018-2023)
Table Cancer Diagnostics Forecasted Revenue Market Size by Regions (2023-2029)
Table Cancer Diagnostics Forecasted Revenue Market Share by Regions (2023-2029)
Figure North America Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure Europe Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure China Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure Japan Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure Korea Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure Southeast Asia Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure India Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure South America Cancer Diagnostics Market Size & Forecast (2018-2029)
Figure Middle East & Africa Cancer Diagnostics Market Size & Forecast (2018-2029)
Table North America Cancer Diagnostics Revenue Share by Players 2022
Table North America Cancer Diagnostics Revenue by Types (2018-2023)
Table North America Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table North America Cancer Diagnostics Revenue by Applications (2018-2023)
Table North America Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table North America Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table North America PEST Analysis
Table Europe Cancer Diagnostics Revenue Share by Players 2022
Table Europe Cancer Diagnostics Revenue by Types (2018-2023)
Table Europe Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table Europe Cancer Diagnostics Revenue by Applications (2018-2023)
Table Europe Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table Europe Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table Europe PEST Analysis
Table China Cancer Diagnostics Revenue Share by Players 2022
Table China Cancer Diagnostics Revenue by Types (2018-2023)
Table China Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table China Cancer Diagnostics Revenue by Applications (2018-2023)
Table China Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table China Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table China PEST Analysis
Table Japan Cancer Diagnostics Revenue Share by Players 2022
Table Japan Cancer Diagnostics Revenue by Types (2018-2023)
Table Japan Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table Japan Cancer Diagnostics Revenue by Applications (2018-2023)
Table Japan Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table Japan Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table Japan PEST Analysis
Table Korea Cancer Diagnostics Revenue Share by Players 2022
Table Korea Cancer Diagnostics Revenue by Types (2018-2023)
Table Korea Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table Korea Cancer Diagnostics Revenue by Applications (2018-2023)
Table Korea Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table Korea Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table Korea PEST Analysis
Table Southeast Asia Cancer Diagnostics Revenue Share by Players 2022
Table Southeast Asia Cancer Diagnostics Revenue by Types (2018-2023)
Table Southeast Asia Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table Southeast Asia Cancer Diagnostics Revenue by Applications (2018-2023)
Table Southeast Asia Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table Southeast Asia Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table Southeast Asia PEST Analysis
Table India Cancer Diagnostics Revenue Share by Players 2022
Table India Cancer Diagnostics Revenue by Types (2018-2023)
Table India Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table India Cancer Diagnostics Revenue by Applications (2018-2023)
Table India Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table India Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table India PEST Analysis
Table South America Cancer Diagnostics Revenue Share by Players 2022
Table South America Cancer Diagnostics Revenue by Types (2018-2023)
Table South America Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table South America Cancer Diagnostics Revenue by Applications (2018-2023)
Table South America Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table South America Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table South America PEST Analysis
Table Middle East & Africa Cancer Diagnostics Revenue Share by Players 2022
Table Middle East & Africa Cancer Diagnostics Revenue by Types (2018-2023)
Table Middle East & Africa Cancer Diagnostics Revenue Market Share by Types (2018-2023)
Table Middle East & Africa Cancer Diagnostics Revenue by Applications (2018-2023)
Table Middle East & Africa Cancer Diagnostics Revenue Market Share by Applications (2018-2023)
Table Middle East & Africa Cancer Diagnostics Revenue, Gross and Gross Margin (2018-2023)
Table Middle East & Africa PEST Analysis
Figure Proportion of Business Cost Structure
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure Cancer Diagnostics Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Research Methodology:
Global Cancer Diagnostics Professional Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|